0 | Good | NO2 | None | None |
42 | Good | O3 PPB | None | None |
63 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
0 | Good | NO2 | None | None |
42 | Good | O3 PPB | None | None |
63 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
0 | Good | NO2 | None | None |
42 | Good | O3 PPB | None | None |
63 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
0 | Good | NO2 | None | None |
43 | Good | O3 PPB | None | None |
63 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
0 | Good | NO2 | None | None |
43 | Good | O3 PPB | None | None |
64 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
0 | Good | NO2 | None | None |
43 | Good | O3 PPB | None | None |
64 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |